Evron
Ella Evron, Baltimore, MD US
Patent application number | Description | Published |
---|---|---|
20090136944 | Aberrantly Methylated Genes as Markers of Breast Malignancy - The invention is directed to a method of diagnosing a cell proliferative disorder of breast tissue by determining the methylation status of nucleic acids obtained from a subject. Aberrant methylation of several genes including TWIST, HOXA5, NES-1, retinoic acid receptor beta (RARĪ²), estrogen receptor (ER), cyclin D2, WT-1, 14.3.3 sigma, HIN-1, RASSF1A, and combinations of such genes serve as markers of breast malignancy. | 05-28-2009 |
Rami Evron, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20080247621 | Method and Apparatus for Positioning a Device in a Tubular Organ - An apparatus and method for detecting, tracking and registering a device within a tubular organ of a subject. The devices include guide wire tip or therapeutic devices, and the detection and tracking uses fluoroscopic images taken prior to or during a catheterization operation. The devices are fused with images or projections of models depicting the tubular organs. | 10-09-2008 |
Tama Evron, Mevasseret Zion IL
Patent application number | Description | Published |
---|---|---|
20090281165 | Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof - The invention relates to an antisense oligonucleotide targeted to the coding region of the human acetylcholinesterase (AChE), which selectively suppresses the AChE-R isoform of the enzyme. The antisense oligonucleotide is intended for use in the treatment and/or prevention of neuromuscular disorders, preferably myasthenia gravis. In addition, it can penetrate the blood-brain barrier (BBB) and destroy AChE-R within central nervous system neurons, while also serving as a carrier to transport molecules across the BBB. | 11-12-2009 |
Yaron Evron, Ness Ziona IL
Patent application number | Description | Published |
---|---|---|
20150228193 | PUBLIC TRANSPORTATION NAVIGATOR - Embodiments of the invention relate to methods for providing information relevant to using a public transportation system (PTS), the method comprising: receiving data relevant to the PTS responsive to a first user while the first user is using the PTS; and providing data relevant to the PTS to at least one of the first and a second user responsive to the received data. The received data may relate to at least one of physically relevant features and socially relevant features of the PTS. Providing data relevant to the PTS may comprise displaying information on a map comprising at least one icon indicative of a PTS vehicle and at a route of travel. | 08-13-2015 |
Yoav Evron, Hod Hasharon IL
Patent application number | Description | Published |
---|---|---|
20090012502 | Oxygen Supply for Cell Transplant and Vascularization - Apparatus is provided, including a housing ( | 01-08-2009 |
20100047311 | PROTECTING ALGAE FROM BODY FLUIDS - Apparatus ( | 02-25-2010 |
20120087111 | SUBMERGED PLANAR ILLUMINATION DEVICE - A submerged planar illumination device for providing specified, substantially uniform distribution of light in liquid from one or few light sources such as LED. The device comprises a light guiding plate having an entrance edge to which the LEDs are fixed, a collimator for redirecting the light and forming substrate light which is coupled to a light guiding plate having at least one light extracting surface. Light extracting surface are optionally on both large surfaces of the light guiding plate. Each light extracting surface is covered with a pattern of light extracting and scattering elements capable of collecting, scattering and extracting light propagating in the light guiding plate into the liquid ambient medium in which the device is submerged. A cover, sealed to the entrance edge of the light guiding plate, protects the light emitting element from the liquid ambient medium. | 04-12-2012 |
Zoharia Evron, Hod-Hasharon IL
Patent application number | Description | Published |
---|---|---|
20090192119 | Inhibition of the Renin-Angiotensin System for the Treatment of Renal, Vascular and Cartilage Pathology - A method of treating a disease or condition in which up-regulating GAGs is therapeutically beneficial is disclosed. The method comprises locally administering to a subject a therapeutically effective amount of an agent capable of down-regulating activity or expression of a component of the renin-angiotensin system. | 07-30-2009 |
20130045933 | ALOE-EMODIN DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF CANCER - The present invention relates to anthracycline derivatives that are based on an Aloe-emodin (AE) backbone attached to a glycoside (an amino sugar or amino carba-sugar). These derivatives are useful as chemotherapeutic agents. Advantageously, these derivatives are potent cytotoxic agents against a variety of anthracycline-resistant tumors. In addition, they may have reduced cardiotoxicity. As such, the novel compounds of the invention offer an advantage over currently available drugs. The present invention further relates to methods for preparing the novel Aloe-Emodin Glycoside (AEG) based derivatives, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as chemotherapeutic agents for prevention and treatment of cancers. | 02-21-2013 |
20140315808 | INHIBITION OF THE RENIN-ANGIOTENSIN SYSTEM FOR THE TREATMENT OF RENAL, VASCULAR AND CARTILAGE PATHOLOGY - A method of treating a disease or condition in which up-regulating GAGs is therapeutically beneficial is disclosed. The method comprises locally administering to a subject a therapeutically effective amount of an agent capable of down-regulating activity or expression of a component of the renin-angiotensin system. | 10-23-2014 |